Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.
Status:
Terminated
Trial end date:
2007-04-27
Target enrollment:
Participant gender:
Summary
This is a phase 4 clinical investigation of the efficacy and safety of Ferrlecit in the
maintenance of iron stores and serum hemoglobin concentration in hemodialysis patients
receiving Erythropoietin.